The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors
Crossref DOI link: https://doi.org/10.1186/s40425-015-0059-z
Published Online: 2015-04-21
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Romano, Emanuela
Romero, Pedro
License valid from 2015-04-21
Article History
Received: 4 March 2015
Accepted: 16 March 2015
First Online: 21 April 2015